Type 2 diabetes mellitus has revealed mechanisms of insulin resistance that target either impairs in β-cell function or insulin insensitive action at adipose tissue, skeletal muscle, or liver tissues. This evidence concerns the gene INS and type 2 diabetes mellitus.